Please enable javascript in your browser in order to view this site.

Neuromancer

A collection of tools for healthcare professionals working with neurological patients.

Made by clinicians for clinicians.

Learn more »

Comprehensive

In our clinical summaries we provide the most essential and clinically relevant information in various aspects of practice. In our Calculators module we strive to provide any tool that could be useful to professionals in our field.

Usable

We develop a tool that we use in our own practice. Our major goals are making the content relevant, discoverable, intuitive and fast.

Up-to-date

All information is provided after review of the most prominent and up-to-date medical literature. We provide links to any original articles or other relevant resources in all content and tools.

Calculators

Vascular disorders

  • ABCD² stroke risk after a TIA
  • ABCD³-I stroke risk after a TIA
  • ABC/2 ICH blood volume calculator
  • ASCOD Stroke phenotypic classification
  • ASPECTS Alberta Stroke Program Early CT Score
  • ATRIA Bleeding risk in patients on anticoagulation
  • Barrow classification system for carotid-cavernous fistulas
  • Borden classification system for dural arteriovenous fistulas
  • CHADS₂ Stroke risk in patients with atrial fibrillation
  • CHA₂DS₂-VASc Stroke risk in patients with atrial fibrillation
  • Cognard classification system for dural arterio-venous fistulas
  • DRAGON 3-month outcome in ischemic stroke after tPA treatment
  • Eligibility for tPA - Exclusion criteria for tPA treatment in acute stroke
  • Framingham CVD 10-year risk for developing cardiovascular disease
  • Fisher Scale - Grading and vasospasm risk calculation in SAH
  • Modified Fisher Scale for SAH
  • FUNC Score - Likelihood of independence after ICH
  • GRASPS Risk of post-tPA hemorrhage
  • GWTG Score In-hospital all-cause heart failure mortality
  • HAS-BLED Score - Bleeding risk in patients on anticoagulation
  • HAT Score - Risk of post-tPA hemorrhage
  • HEMORR₂HAGES Score - Risk of major bleeding
  • Hunt & Hess Classification and outcome in SAH
  • ICH Score - Mortality after ICH
  • NIH Stroke Scale
  • Ogilvy and Carter Grading - Outcome in aneurysmal SAH
  • PHASES Score - Aneurysm rupture risk
  • Spetzler-Martin Grading for arterio-venous malformations
  • UIATS Score - Management of unruptured intracranial aneurysms
  • WFNS Scale - Outcome in SAH

Neurointensive Care

  • AAN Brain Death Criteria
  • FOUR Score - Full Outline of UnResponsiveness Score for coma
  • GCS - Glasgow Coma Scale
  • Pediatric GCS
  • Ramsay Sedation Scale
  • Richmond Agitation-Sedation Scale

Neuroinflammatory disorders

  • McDonald Criteria - The 2010 Revised McDonald Criteria for MS
  • Risk for PML in Natalizumab treated patients

Disability scales

  • EDSS - Expanded Disability Status Scale
  • Glasgow Outcome Scale for disability after cerebral injury
  • Modified Ashworth Scale for spasticity
  • Modified Rankin Scale for disability
  • Oxford handicap scale

Movement disorders

  • UPDRS - Unified Parkinson's Disease Rating Scale (not MDS-UPDRS)
  • L-Dopa Equivalent Dose Calculator

Neuromuscular disorders

  • ALSFRS-R - Amyotrophic Lateral Sclerosis Functional Rating Scale Revised
  • El Escorial Criteria - Diagnostic criteria for ALS
  • House-Brackmann Grading system for facial nerve palsy
  • mEGOS - Modified Erasmus GBS Outcome Score
  • Quantitative Myasthenia Gravis (QMG) test
  • Revised Airlie House criteria for ALS

Pharmacology related

  • Anticoagulant Switcher - Recommendations when switching between anticoagulants
  • Drug Interactions Finder - Find interactions of single or multiple drugs

Various

  • MDRD GFR - eGFR calculator using the MDRD formula
  • Body mass index calculator
  • Body surface area calculator

Neuropharmacology summaries

Comprehensive summaries including pharmacokinetics, metabolism, drug interactions, dosing suggestions and dose adjustment in patients with impaired renal or hepatic function.

  • Antithrombotics including all newer anticoagulant and antiplatelet drugs.
  • Antiepileptics including all newer antiepileptic drugs.
  • Antiparkinsonian drugs.

Clinical summaries and quick-refs

  • The current evidence-based recommended treatment algorithm for convulsive status epilepticus.
  • Comprehensive coverage of stroke syndromes per artery
  • Ischemic stroke
  • Nontraumatic ICH
  • Epidural hematoma
  • Acute subdural hematoma
  • Subarachnoid hemorrhage
  • Movement disorder emergencies
  • Neuromuscular emergencies
  • More content added in each new release

Neuroanatomy and localization aids

  • Dermatome maps
  • Full reference of peripheral nerves, searchable by root, innervated muscle or sensory area.
  • Cranial nerve reference.
  • Arterial perfusion maps of the brain.
  • Arterial anatomy of the brain.
  • More coming soon!

New in version 1.4.6

New in Emergencies module

Neuromuscular emergencies section
  • Respiratory management in NMD patients
  • Drug considerations in NMD patients
  • Guillain-Barré syndrome
  • Acute Porphyria
  • Myasthenic crisis
  • Botulism

New in Calculators module

  • The Quantitative Myasthenia Gravis (QMG) Test

Neuromancer Lite is now ad-free

After a brief trial, we have decided to remove all ads from Neuromancer Lite. We believe a usable and non-distracting user interface is of paramount importance in applications of this kind. Most content is available in Neuromancer Lite. Selected topics and some future modules will only be available in the paid version of Neuromancer.

New in version 1.4.5

Movement disorders emergencies

  • Neuroleptic malignant syndrome
  • Serotonine syndrome
  • Malignant catatonia
  • Dystonic storm
  • Oculogyric crisis
  • Malignant Tourette syndrome
  • Psychosis in Parkinson's disease

New in version 1.4.4

Neuromancer Lite now available

We are making parts of Neuromancer freely available. This includes most of the Calculators module and selected content from Emergencies, Pharmacology, Vascular, Cranial and Peripheral nerves modules. Search functionality works as expected.

New in version 1.4.3

New content in Emergencies module

  • Epidural hematoma
  • Acute subdural hematoma
  • Subarachnoid hemorrhage

New in version 1.4.2

New content in Emergencies module

  • Nontraumatic parenchymal hemorrhage

New in version 1.4.1

New content in Emergencies module

  • Ischemic stroke

New in version 1.4

New content in Vascular territories module

  • Brain venous anatomy reference
  • Review of cerebral venous thrombosis

Improved startup time

Indexing content happens at first startup after install or update. Subsequent startups are almost instantaneous.

New in version 1.3

New content in Vascular territories module

  • Brain arterial and venous anatomy reference
  • Review of stroke syndromes organized per-vessel
  • Review of venous sinus thrombosis syndromes

Search function improvements

Search result views are automatically scrolled to the portion matching the given search term and the relevant text is highlighted.

Upcoming changes

New Emergencies module currently contains a single section on status epilepticus. We will be adding sections incrementally as soon as they are complete.

Calculators module is free

Starting from version 1.3 the Calculators module can be installed as a free, stand-alone app: Neuromancer Lite.

Enter your email address if you want us to get back to you. We'll never share your email with anyone else.

About us

Our aim at Neuraxis is to provide valuable and affordable tools for experts working with neurologic patients. Neuromancer is our debut product and is being actively developed, with new content introduced in every new release.


Consider leaving a review

If you like Neuromancer please consider leaving a review. Good reviews make an app more discoverable in the AppStore. Having more people using the app means having less bugs, more features and thus better value for your money.

If you are unsatisfied with the app, please consider letting us know why before leaving a bad review. If you have found a bug, an omission or other undesirable behavior, your feedback will help us correct it and improve your experience.


We would like to hear from you

If you need a tool that we are missing or have other suggestions, use our contact form to leave your suggestions or feedback.

Disclaimer


A. Terms of Use Agreement

By accessing this website and reading its content or using the Neuraxis AB mobile applications, you acknowledge and agree that you have read, understood and accepted these terms and conditions, that the provisions, disclosures and disclaimers set forth herein are fair and reasonable and that your agreement to follow and be bound by these therms and conditions is voluntary and is not the result of fraud, duress or undue influence exercised upon you by any person or entity.

1. No advice

The information provided by Neuraxis AB is not medical advice and should not be regarded as an alternative to medical advice, diagnosis or treatment from a professional healthcare provider.

2. No warranties

The information made available in this website or the mobile applications is provided "as is" and "as available" without warranties of any kind, either express or implied. Under no circumstances, as a result of your use of the website or mobile applications, will Neuraxis AB be liable to you or to any other person for any direct, indirect, incidental, consequential, special, exemplary or other damages under any legal theory, including, without limitation, tort, contract, strict liability or otherwise, even if advised of the possibility of such damages.

3. Legal disclaimer

This website or provided mobile applications should not be used in any legal capacity whatsoever, including but not limited to establishing "standard of care" in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions expressed on the website and mobile applications.

4. Indemnification

You agree to defend, indemnify and hold Neuraxis AB harmless from and against any and all claims, damages, costs including attorneys' fees, arising from or related to your use of the website or its mobile applications.

B. Copyright

1. Ownership of copyright

Neuraxis AB owns the copyright to this website and its material. Neuraxis AB owns the copyright to its mobile applications and their material.

2. Copyright license

Neuraxis AB grants you license to access, print or store the information provided in this website or mobile applications for non-commercial purposes and provided that the following clause on reverse engineering (see paragraph 3) is upheld. No other permissions or rights to Neuraxis AB owned material are granted. All other rights are reserved.

3. Reverse engineering

Licensee will not reverse engineer, decompile, disassemble or otherwise attempt to derive the source code, content of bundled databases, techniques, processes, algorithms, know-how or other information from Neuraxis AB website or mobile applications (collectively, "Reverse Engineering") or permit or induce the foregoing. If directly applicable law prohibits enforcement of the foregoing, Licensee may engage in Reverse Engineering solely for purposes of obtaining such information as is necessary to achieve interoperability of independently created software with the Neuraxis AB Technology, or as otherwise and to the limited extent permitted by directly applicable law, only if: (a) Reverse Engineering is strictly necessary to obtain such information, and (b) Licensee has first requested such information from Neuraxis AB and Neuraxis AB failed to make such information available (for a fee or otherwise) under reasonable terms and conditions. Any information supplied to or obtained by Licensee under this section is confidential information of Neuraxis AB, may only be used by Licensee and will not be disclosed to any third party or used to create any software which is substantially similar to the expression of the Neuraxis AB Technology.